Cesarean Scar Pregnancy and Clinical Outcomes

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Jul 28, 2022

Keywords

ClinConnect Summary

This clinical trial, led by Professor Zhao Yangyu at Peking University Third Hospital, is looking at a specific condition called cesarean scar pregnancy. This happens when a pregnancy grows in the scar tissue from a previous cesarean section (C-section). The study aims to understand the risks and outcomes for women with this condition, including potential issues like blood loss, the need for additional surgeries, or the risk of miscarriage.

To participate in this trial, women must be at least 20 years old, have been diagnosed with a cesarean scar pregnancy, and be less than 14 weeks pregnant. They should also plan to receive care and give birth at the study hospital. Women who cannot give informed consent or have mental health disorders will not be eligible. If you qualify, you can expect to receive prenatal care and be closely monitored throughout your pregnancy as part of the study. This research could help improve care for future patients facing similar challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Female aged ≥ 20 years
• • Female with cesarean scar pregnancy
• • Less than 14 gestational weeks
• • Planning to receive prenatal healthcare and delivery service at the study hospital
• Exclusion Criteria:
• • Inability to provide informed consent
• • Women with mental disorders